These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 30852982)

  • 21. International normalized ratio testing with a point-of-care coagulometer in 1-month-old infants: A comparison with Normotest.
    Iijima S; Baba T; Ueno D; Ohishi A
    Thromb Res; 2016 Sep; 145():72-7. PubMed ID: 27500369
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of the Roche CoaguChek XS handheld coagulation analyzer in a cardiac outpatient clinic.
    Nam MH; Roh KH; Pak HN; Lee CK; Kim YH; Lee KN; Cho Y
    Ann Clin Lab Sci; 2008; 38(1):37-40. PubMed ID: 18316780
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Evaluation of CoaguChek XS for measuring prothrombin time in patients receiving long-term oral anticoagulant therapy].
    Lee JH; Lee KS; Kim DS; Lee HS; Choi SI; Cho YG
    Korean J Lab Med; 2007 Jun; 27(3):177-81. PubMed ID: 18094572
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Accuracy of capillary whole blood international normalized ratio on the CoaguChek S, CoaguChek XS, and i-STAT 1 point-of-care analyzers.
    Karon BS; McBane RD; Chaudhry R; Beyer LK; Santrach PJ
    Am J Clin Pathol; 2008 Jul; 130(1):88-92. PubMed ID: 18550476
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The reliability of point-of-care prothrombin time testing. A comparison of CoaguChek S and XS INR measurements with hospital laboratory monitoring.
    Ryan F; O'Shea S; Byrne S
    Int J Lab Hematol; 2010 Feb; 32(1 Pt 1):e26-33. PubMed ID: 19032373
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sensitivity of commercial prothrombin time reagents to detect coagulation factor deficiencies in equine plasma.
    Mischke R; Junker J; Deegen E
    Vet J; 2006 Jan; 171(1):114-9. PubMed ID: 16427588
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Performance of the microINR Point-of-Care System: A Multicenter Clinical Trial.
    Refaai MA; Shah V; Fernando R
    Thromb Haemost; 2020 Apr; 120(4):687-691. PubMed ID: 32299116
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of a point-of-care coagulation analyzer for measurement of prothrombin time, activated partial thromboplastin time, and activated clotting time in dogs.
    Tseng LW; Hughes D; Giger U
    Am J Vet Res; 2001 Sep; 62(9):1455-60. PubMed ID: 11560277
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of the international normalized ratio levels obtained by portable coagulometer and laboratory in a clinic specializing in oral anticoagulation.
    Meneghelo ZM; Barroso CM; Liporace IL; Cora AP
    Int J Lab Hematol; 2015 Aug; 37(4):536-43. PubMed ID: 25754527
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of telavancin on prothrombin time and activated partial thromboplastin time as determined using point-of-care coagulometers.
    Ero MP; Harvey NR; Harbert JL; Janc JW; Chin KH; Barriere SL
    J Thromb Thrombolysis; 2014; 38(2):235-40. PubMed ID: 24132401
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of home prothrombin international ratio (PT-INR) management in children with mechanical prosthetic valves - Importance of individual correlations between laboratory and CoaguChek device PT-INRs.
    Ino N; Masutani S; Tanikawa S; Iwamoto Y; Saiki H; Ishido H; Tamura M; Senzaki H
    J Cardiol; 2018 Feb; 71(2):187-191. PubMed ID: 29066099
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Performance evaluation of the new CoaguChek XS system compared with the established CoaguChek system by patients experienced in INR-self management.
    Braun S; Watzke H; Hasenkam JM; Schwab M; Wolf T; Dovifat C; Völler H
    Thromb Haemost; 2007 Feb; 97(2):310-4. PubMed ID: 17264962
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Validation of the CoaguChek XS international normalised ratio point-of-care analyser in patients at Charlotte Maxeke Johannesburg Academic Hospital, South Africa.
    Benade EL; Jacobson BF; Louw S; Schapkaitz E
    S Afr Med J; 2016 Feb; 106(3):280-3. PubMed ID: 26915943
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Point-of-Care Coagulation Testing for Trauma Patients in a Military Setting: A Prospective Study.
    Cotte J; d'Aranda E; Chauvin V; Kaiser E; Meaudre E
    J Spec Oper Med; 2013; 13(4):59-62. PubMed ID: 24227563
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Therapeutic concordance of two portable monitors and two routine automatic oral anticoagulant monitoring systems using as reference the manual prothrombin time technique.
    Vacas M; Lafuente PJ; Unanue I; Santos M; Iriarte JA
    Hematol J; 2003; 4(3):214-7. PubMed ID: 12764354
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Performance evaluation of coaguchek pro II in comparison with coaguchek XS plus and sta-r Max using a sta-neoplastine CI plus.
    Nam M; Hur M; Kim H; Yoon S; Lee S; Shin S; Moon HW; Yun YM
    Int J Lab Hematol; 2021 Oct; 43(5):1191-1197. PubMed ID: 33460254
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Point-of-care PT and aPTT in patients with suspected deficiencies of coagulation factors.
    Niederdöckl J; Dempfle CE; Schönherr HR; Bartsch A; Miles G; Laggner A; Pathil A
    Int J Lab Hematol; 2016 Aug; 38(4):426-34. PubMed ID: 27384253
    [TBL] [Abstract][Full Text] [Related]  

  • 38. INR comparison between the CoaguChek Pro PT(N) and a standard laboratory method.
    Khoschnewis S; Hannes FM; Tschopp M; Wuillemin WA
    Thromb Res; 2004; 113(5):327-32. PubMed ID: 15183045
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Is perioperative point-of-care prothrombin time testing accurate compared to the standard laboratory test?
    Urwyler N; Staub LP; Beran D; Deplazes M; Lord SJ; Alberio L; Theiler L; Greif R
    Thromb Haemost; 2009 Oct; 102(4):779-86. PubMed ID: 19806266
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Accuracy and clinical usefulness of the CoaguChek S and XS Point of Care devices when starting warfarin in a hospital outreach setting.
    Sobieraj-Teague M; Daniel D; Farrelly B; Coghlan D; Gallus A
    Thromb Res; 2009 Apr; 123(6):909-13. PubMed ID: 19042011
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.